Gastro-entero Pancreatic Neuroendocrine Tumors
3 clinical trials · Condition
◉ Watch Gastro-entero Pancreatic Neuroendocrine Tumors
| Record | Firm | Date |
|---|---|---|
| Protocol ITANET - Registry (NCT04282083) | Italian Association Neuroendocrine Tumors | 2019-05-25 |
| 177Lutethium - Peptide Receptor Radionuclide Therapy (Lu-PRRT) Plus Capecitabine Versus Lu-PRRT in FDG Positive, Gastro-entero-pancreatic Neuroendocrine Tumors (NCT02736448) | Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS | 2016-05-01 |
| Peptide Receptor Radionuclide Therapy With 177Lu-Dotatate Associated With Metronomic Capecitabine In Patients Affected By Aggressive Gastro-Etero-Pancreatic Neuroendocrine Tumors (NCT02736500) | Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS | 2015-09-02 |
Track Gastro-entero Pancreatic Neuroendocrine Tumors automatically
Every clearance here is in the API, with alerts when new ones post.